Cardio Diagnostics (CDIO) Revenue & Revenue Breakdown
Cardio Diagnostics Revenue Highlights
Latest Revenue (Y)
$2.02K
Latest Revenue (Q)
$6.58K
Cardio Diagnostics Revenue by Period
Cardio Diagnostics Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-12-31 | $2.02K | -88.14% |
2023-12-31 | $17.07K | 1696.32% |
2022-12-31 | $950.00 | 5.44% |
2021-12-31 | $901.00 | 100.00% |
2020-12-31 | - | - |
Cardio Diagnostics generated $2.02K in revenue during NA 2024, up -88.14% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Cardio Diagnostics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $6.58K | -16.39% |
2024-06-30 | $7.87K | -50.59% |
2024-03-31 | $15.93K | 199.96% |
2023-12-31 | $5.31K | -47.06% |
2023-09-30 | $10.03K | 481.45% |
2023-06-30 | $1.73K | 100.00% |
2023-03-31 | - | -100.00% |
2022-12-31 | $950.00 | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | -100.00% |
2021-12-31 | $901.00 | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | - |
Cardio Diagnostics generated $6.58K in revenue during Q3 2024, up -16.39% compared to the previous quarter, and up 381.45% compared to the same period a year ago.
Cardio Diagnostics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
PYXS | Pyxis Oncology | $16.15M | - |
SONN | Sonnet BioTherapeutics | $147.81K | $1.00M |
CDIO | Cardio Diagnostics | $2.02K | $6.58K |
ZVSA | ZyVersa Therapeutics | - | - |
IMMX | Immix Biopharma | - | - |
ZURA | Zura Bio | - | - |
PHIO | Phio Pharmaceuticals | - | - |
CNSP | CNS Pharmaceuticals | - | - |
ATNF | 180 Life Sciences | - | - |
ELEV | Elevation Oncology | - | - |